...
首页> 外文期刊>Interdisciplinary Neurosurgery >Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis Administration in an Acute Ischemic Stroke Patient with Chronic Pontine Microbleeds, a Case Report
【24h】

Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis Administration in an Acute Ischemic Stroke Patient with Chronic Pontine Microbleeds, a Case Report

机译:患有急性缺血性脑卒中患者患者慢性猪微微脑卒中患者症状后的症状脑内出血,案例报告

获取原文
           

摘要

Symptomatic intracerebral hemorrhage (sICH) is the most concerning complication of intravenous thrombolysis with recombinant tissue plasminogen (rTPA) occurring in 6% of cases and is associated with a 50% mortality. The presence of pre-thrombolysis cerebral microbleeds (CMB) is considered a risk factor for sICH and poor functional outcome but there is still lack of evidence on the significant impact of CMB number and anatomical distribution. To date, there are no reports describing the relationship between brainstem microbleeds and post-thrombolysis sICH. We report a case of a 47?year old male diagnosed with acute ischemic infarcts on the left corona radiata and left posterior internal and external capsule, with five CMBs - one on the right temporal lobe, another on the right thalamus, and three in the pons. He was given Intravenous (IV) rTPA within 20?min post-ictus with initial improvement of deficits. However, on the second hour post-rTPA, there was clinical deterioration with evidence of intraparenchymal hemorrhage on the left frontal lobe and pons. This case report highlights the presence of chronic brainstem microbleeds as a potential predictor of sICH and a valuable factor when deciding on giving IV rTPA in acute ischemic stroke.
机译:症状脑出血(SICH)是在6%病例中发生的重组组织纤溶酶原(RTPA)的静脉内溶栓的复杂性最多,与50%的死亡率相关。预溶栓脑微微β(CMB)的存在被认为是SICH和功能性差异差的危险因素,但仍然缺乏关于CMB数量和解剖分布的显着影响的证据。迄今为止,没有报告描述脑干微斑秃和溶栓后杆菌之间的关系。我们举报了一个47岁的案件患有左电晕radiata的急性缺血性梗死和留下后部和外部​​胶囊的案例,用五个CMBS - 一个在右颞叶上,另一个在右丘脑上,三个帕。他在20年内给予静脉注射(iv)rtpa,初步改善了赤字。然而,在rtpa后第二小时,临床劣化,左前叶和PONS上的脑内失血证明。本病例报告突出了慢性脑干的存在微妙的脑干作为SICH的潜在预测因子以及在决定在急性缺血性卒中赋予IV RTPA时的有价值的因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号